Self-Administered Drug Exclusion List
Supported manufacturer MAC strategies to overcome MAC SAD exclusion list designation.
Supported manufacturer MAC strategies to overcome MAC SAD exclusion list designation. Worked with former Medicare Administrative Contractor (MAC) Contractor Medical Director advisors to understand the criteria in the evaluation process, in concert with Medicare regulatory references on Part B coverage criteria. Led MAC advocacy engagement strategy to overcome decision and preserve Part B coverage.
CEO insights
Related articles
Real analysis from people who’ve been there
Evaluation of Biosimilar Utilization by Hospital Types
Worked with a pharmaceutical trade organization to identify biosimilars of interest.
Advocacy Coalition for Uptake of Comprehensive Genomic Profiling
Worked with a diverse group of industry stakeholders including diagnostics manufacturers, laboratories, academic institutions, and disease-specific advocacy groups to redefine comprehensive genomic profiling through the creation of a “new narrative”.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.